Found 5 matching trials
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
PHASE2Evaluation of efficacy and safety of MGN1703 administered twice weekly subc...
Location
Medizinische Universitaet Innsbruck
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
University of Texas MD Anderson Cancer Center
Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma
PHASE2This is a phase 2, randomized, double-blind, multi-center clinical study to...
Location
Klinik für Innere Medizin I, Abteilung für Klinische Onkologie, Medizinische Universität Wien
Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection
PHASE1Combination antiretroviral treatment (cART) effectively suppresses virus re...
Location
Department for Infectious Diseases, Aarhus University Hospital
Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment
PHASE3The purpose of this this trial is to prove the efficacy and safety of MGN17...
Location
Landesklinikum Krems